Finanzwire Finanzwire
Basculer en Français
11335 Companies
251957 Keywords
181306 Articles
137774 Press releases
Headlines Articles Press releases POP Biotechnologies, Inc. Remove
  1. Home
  2. Companies
  3. POP Biotechnologies, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/27/2024 at 20:05, 2 years 1 month ago

    POP Biotechnologies Announces Positive Interim Results for COVID-19 Vaccine Trial

    COVID-19 Vaccine Phase 3 Trial Immunogenicity EuCorVac-19 POP BIO SNAP
  • PRESS RELEASE

    published on 09/27/2024 at 20:00, 2 years 1 month ago

    POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

    POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant
    COVID-19 Vaccine Phase 3 Trial POP Biotechnologies EuBiologics ECV-19
    Logo of POP Biotechnologies, Inc.
  • PRESS RELEASE

    published on 07/14/2023 at 18:00, 3 years 3 months ago

    POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    Logo of POP Biotechnologies, Inc.
Accesswire
  • Published on 11/13/2026 at 20:15, 1 hour 48 minutes ago

    U.S. Export-Import Bank Features NioCorp's Elk Creek Critical Minerals Project in EXIM's Factory Floor Fridays Initiative

  • Published on 11/13/2026 at 18:30, 3 hours 33 minutes ago

    Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario

  • Published on 11/13/2026 at 18:05, 3 hours 58 minutes ago

    Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026

  • Published on 11/13/2026 at 17:25, 4 hours 38 minutes ago

    Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year

  • Published on 11/13/2026 at 15:40, 6 hours 23 minutes ago

    Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.

View all ACCESSWIRE
EQS Group
  • Published on 11/13/2026 at 21:52, 10 minutes ago

    EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026

  • Published on 11/13/2026 at 19:15, 2 hours 48 minutes ago

    Increase in Equity to Accelerate Growth

  • Published on 11/13/2026 at 19:08, 2 hours 54 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026

  • Published on 11/13/2026 at 18:04, 3 hours 58 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved

  • Published on 11/13/2026 at 17:14, 4 hours 48 minutes ago

    Issue of Equity

View all EQS
Les Echos
  • Published on 11/13/2026 at 11:35, 10 hours 28 minutes ago

    ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France

  • Published on 11/12/2026 at 23:12, 22 hours 50 minutes ago

    Belgrano continues the implementation of its public share buyback offer (OPRA)

  • Published on 11/12/2026 at 18:36, 1 day 3 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

  • Published on 11/12/2026 at 18:00, 1 day 4 hours ago

    Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026

  • Published on 11/12/2026 at 17:40, 1 day 4 hours ago

    Financial information for the period ended 30 September 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy